The Trump administration's Justice Department asked a court to dismiss a lawsuit by Idaho, Kansas, and Missouri that seeks to limit telehealth access to mifepristone, a common abortion medication. The government contended these states lack legal standing to sue. The lawsuit emerged after the Supreme Court maintained access to the drug, seeking to reinstate strict requirements including in-person consultations. The matter is under the jurisdiction of U.S. District Judge Matthew Kacsmaryk, known for his earlier ruling against the drug's approval, but DOJ attorneys indicated that states could refile in a suitable venue.
"The states are free to pursue their claims in a district where venue is proper, but the states' claims before this court must be dismissed or transferred..."
"The lawsuit from Idaho, Kansas and Missouri argues that FDA should roll back access to mifepristone...after the Supreme Court preserved access to mifepristone last year."
Collection
[
|
...
]